. Postnatally, FMRP is localized in the cell body, proximal dendrites and axons of neurons (Darnell et al., 2011; Castrén, 2016) , and plays profound regulatory roles in the synaptic function and neuronal plasticity (Bassell and Warren, 2008; De Rubeis and Bagni, 2010) through interaction with transcripts that encode pre-and postsynaptic proteins, and also regulation of mRNA trafficking into dendrites (Abrahams and Geschwind, 2008; Bassell and Warren, 2008; Abrahams et al., 2013) .
ABSTRACT Fragile X mental retardation protein (FMRP) is encoded by FMR1 gene that is responsible for Fragile X Syndrome (FXS) showing intellectual disability and autism spectrum disorder. FMRP is an RNA binding protein highly expressed in the brain.
Although several target genes for FMRP have been identified, limited studies have suggested the role of FMRP in corticogenesis. Here we performed RNA immunoprecipitation sequencing against the murine embryonic neocortex, and identified 124 genes as potential FMRP mRNA targets. We found 48 of these genes as overlapped with autism-related genes, which were categorized in four functional groups: "transcriptional regulation", "regulation of actin cytoskeleton", "ubiquitin-mediated proteolysis" and "calcium signaling pathway". Four of these genes showed significant difference in expression in the cortical primordium of Fmr1-KO mice; Huwe1 and Kat6a increased, while Kmt2c and Apc decreased. Although the change in expression of these four genes was relatively small, these subtle changes due to dysregulated transcription could collectively contribute to impaired corticogenesis to cause phenotypes of FXS. Investigating the transcriptional control of FMRP on its mRNA targets may provide new insight to understand neurodevelopmental pathogenesis of FXS.
INTRODUCTION
Fragile X Syndrome (FXS) is an X-linked neurodevelopmental disorder that causes intellectual disability as well as behavioral deficits. Among genetically caused cases of autism spectrum disorder (ASD), the most frequent neurodevelopmental disorder, 1-2% of the patients exhibit FXS (Abrahams and Geschwind, 2008; Garber et al., 2008; Dahlhaus, 2018) . Patients with FXS have an abnormal expansion of CGG repeats in the 5'-untranslated region of the gene, fragile X mental retardation (FMR1). This results in the hypermethylation and transcriptional silencing of the gene, which lead to the loss of its product fragile X mental retardation 1 protein (FMRP) (Verkerk et al., 1991; Ashley Jr. et al., 1993; Bakker et al., 1994; Crawford et al., 2001; Garber et al., 2008) . FMRP is a polyribosome-associated RNA-binding protein (RBP) that selectively targets specific mRNAs, regulates its translation, transport, and stability, as well as histone modification and chromatin remodeling (Bassell and Warren, 2008; De Rubeis and Bagni, 2010; Alpatov et al., 2014; Korb et al., 2017) . Hence, FMRP is a multifunctional protein that could be involved in diverse processes, not limited to the mRNA lifecycle.
FMRP is widely expressed in the embryonic and adult brain. During corticogenesis, it is expressed in neural stem cells (or radial glial cells, RGCs), localizing at the apical and basal endfeet of the RGCs (Saffary and Xie, 2011; La Fata et al., 2014; Pilaz et al., 2016) , regulates transition from RGC to intermediate progenitor (Saffary and Xie, 2011) , and affects neuronal migration and cortical circuitry (La Fata et followed by microarray analysis (Brown et al., 2001; Pilaz et al., 2016) , crosslinking immunoprecipitation followed by high-throughput sequencing (Darnell et al., 2011) , and photoactivetable ribboneoside-enhanced crosslinking and immunoprecipitation (Ascano et al., 2012) . However, an inclusive research to identify FMRP mRNA targets and their roles is limited during brain development compared with those in postnatal stages.
In this study, we identified a large number of FMRP mRNA targets using RIP high-throughput sequencing in the mouse embryonic cortex. These FMRP target genes showed highly significant overlap with ASD-related genes. We found that these molecules were associated with "transcriptional regulation", "regulation of actin cytoskeleton", "ubiquitin-mediated proteolysis" and "calcium signaling pathway".
Among the candidate FMRP mRNA targets, the expression levels of Huwe1 and Kat6a were increased and those of Kmt2c and Apc were decreased in the Fmr1-knockout (KO) mice (Bakker et al., 1994) , implying a possibility that FMRP may regulate its mRNA targets at the level of transcription. The dysfunction of FMRP may thus lead to changes the developmental program during corticogenesis in multiple ways.
RESULTS

FMRP expression in the mouse embryonic cortex
We first tried to confirm the expression of FMRP in the neocortical primordium of wild type (WT) mice at embryonic day (E) 14.5 when massive neurogenesis occurs. FMRP was accumulated at apical and pial (basal) surface areas of the cortical primordia ( Figure 1A -C). To confirm the detailed expression of FMRP in the surface areas of the cortex, we labeled the RGCs using in utero electroporation with pCAG-EGFP at E13.5 mice, and sacrificed at E14.5. Immunostaining revealed that the FMRP protein was overlapped with GFP in the apical and basal endfeet of the RGCs (Figure 1D -I). We also observed strong expression of FMRP in the cortical plate consisting with immature neurons ( Figure 1A -C), which has not been reported in the above-mentioned previous studies (Saffary and Xie, 2011; La Fata et al., 2014; Pilaz et al., 2016) . This may be attributed to difference in antibodies used, although it is not surprising that FMRP is indeed expressed in neurons of adult mice (Darnell et al., 2011; Maurin et al., 2018) .
Identification of FMRP target mRNAs in embryonic mouse cortex
To explore mRNA targets of FMRP during corticogensis, we performed RIP-sequencing (RIP-seq, Figure S1 ) using the cortical primodium samples isolated from E14.5 WT mice. In total, we found 3,954 transcripts that showed significant difference in expression (FDR<0.01), 2,288 of which were enriched in the FMRP-IP compared to the IgG-IP. We identified a stringent set of 947 transcripts from 865 candidate FMRP mRNA targets based on fold-change (log 2 FC>1) and FMRP-IP (FPKM>10) gene expression to prevent signal to noise issues from the sequencing ( Figure 2A ). This set of FMRP mRNA targets showed higher mRNA abundance compared to negative control and could thus be validated as candidate targets of FMRP in the developing neocortex.
To estimate functions of the FMRP target candidates, we used gene ontology (GO) term using the Visual Annotation Display (VLAD) -gene analysis and visualization analysis tool of the Mouse Genome Informatics (MGI) (Smith et al., 2018) .
The top significant GO terms included biological processes involved in early brain development such as "nervous system development", "generation of neurons", "neurogenesis", "neuron development", "neuron differentiation", and "neuron projection development" (Figure 2B ). This is quite reasonable because FMRP has been shown to play an important role in maintaining the RGCs, i.e., the main source of neurons during brain development (Saffary and Xie, 2011; Götz and Barde, 2005) . Thus, FMRP may participate in cortical neurogenesis via regulating various mRNA targets.
Overlap the FMRP targets with ASD-associated genes
To search for a link between FXS to ASD, we compared our 865 FMRP target genes with 1162 ASD-associated genes from Simons Foundation Autism Research Initiative (SFARI, retrieved last March 11, 2019) (Abrahams et al., 2013) . There was a highly significant overlap of 124 candidate FMRP target genes and ASD-associated genes (p=3.41x10 -24 ; Figure 2C , Supplementary Table 1 ). This overlap included several well-studied, syndromic ASD-associated genes like HECT, UBA And WWE Domain Containing E3 Ubiquitin Protein Ligase 1 (HUWE1), neurofibromatosis 1 (NF1), Nipped-B homolog (NIPBL), nitric oxide synthase 1 (NOS1), and paired box 6 (PAX6).
The results obtained here may suggest a possible explanation for the common phenotypes of FXS and ASD during neural development.
(see Supplementary Table 1 for full names of the genes). The second cluster was "regulation of actin cytoskeleton" comprised of 8 genes, i.e., Apc, Cyfip1, Dock1, Fgfr2, Iqgap1, Mapk3, Nckap1, and Pik3r2 . The third cluster was "ubiquitin-mediated proteolysis" comprised of 7 genes, i.e., Birc6, Cul7, Huwe1, Trip12, Ube2h, Ube3c and Ube3h. The last cluster was "calcium signaling pathway" comprised of 5 genes, i.e., Cacna1h, Gnas, Itpr1, Nos1 and Plcb1. Other proteins may also have the similar functions, although they did not appear in our current pathway analyses. Above evidence may imply multiple functions of FMRP through various target molecules.
Confirmation of mRNA targets regulated by FMRP during corticogenesis
To validate the targets identified by RIP-seq, enrichment analysis of the mRNA targets in the four functional clusters was performed using RIP-qPCR of the embryonic dorsal telencephalon. 46 out of the 48 targets in the above mentioned four clusters showed significant enrichment in the FMRP-IP compared with that in the quality control (QC-input) ( Figure 4 ). The top six most enriched targets with an expression fold-change greater than 20 (FC>20) were Per1, Chd8, Cul7, Dock1, Pik3r2 and Itpr1. It is thus considered that the 46 targets are reliable as candidates for FMRP targets that may have impact on corticogenesis.
The most known functions of FMRP are posttranscriptional regulation of its target mRNAs, e.g., transportation and translation within the cell (see review by Pilaz and Silver, 2015) . However, we wondered if there is any possibility of regulation at the level of transcription. We thus performed RT-qPCR of FMRP target candidate genes using the embryonic dorsal telencephalon obtained from WT and Fmr1-KO mice at E15.5. Most of the 46 enriched FMRP targets did not show different expression levels between WT and Fmr1-KO mice, although there were four genes that showed difference in expression ( Figure 5 ). Huwe1 and Kat6a showed increased expression, while Kmt2c (also known as Mll3) and Apc showed decreased expression in Fmr1-KO mice. Therefore, it can be possible that these four mRNA targets are regulated at the level of transcription.
FMRP influences mRNA stability Kmt2c and Apc
To assess whether the decrease in mRNA amount of Kmt2c and Apc in vivo was resulted from reduced stability of mRNA or not, we performed mRNA stability assay using primary culture of cortical astrocytes and embryonic fibroblasts (MEFs) taken from Fmr1-KO and WT mice. We performed a time-course evaluation of mRNA amount of the genes in the cultured astrocytes and MEFs treated with actinomycin D, a transcription inhibitor (Bensaude, 2011) . After transcriptional blockade, Kmt2c and Apc mRNA amount showed a similar level between WT and Fmr1-KO astrocytes ( Figure   6A , B). In MEFs, mRNA amount of Apc was reduced by 13.5% in Fmr1-KO than that of WT at 4 hours after actinomycin D treatment, while Kmt2c mRNA showed reduction in mRNA amount in Fmr1-KO at 2-hr (26.3%) and 4 hours (40.9%) after the treatment ( Figure 6C , D). These results suggest that FMRP could contribute to the mRNA stability of Kmt2c, at least, in cultured MEFs.
DISCUSSION
Functions of FMRP have been reported to include regulation of translation, transport, and stability (De Rubeis and Bagni, 2010; Darnell et al., 2011; Ascano et al., 2012; La Fata et al., 2014; Pilaz et al., 2016; Liu et al., 2018) . Although mechanisms are not fully elucidated at molecular and cellular levels, several FMRP mRNA targets are linked to various neurobiological processes such as neuronal migration and circuitry formation (La Fata et al., 2014) , synaptogenesis (Darnell et al., 2011) , DNA damage response (Alpatov et al., 2014) , and epigenetic regulation (Korb et al., 2017) . Therefore, to identify mRNAs that are controlled by FMRP is essential for elucidation of its roles in brain development by controlling the target molecules and for determination of its contribution to pathogenesis of FXS and related neurodevelopmental disorders.
Here, we identified FMRP mRNA targets in murine corticogenesis. Among 865 genes obtained from RIP-seq, 124 are listed in SFARI database for autism-related genes, suggesting common roles of FMRP in FXS and ASD. In other words, various symptoms such as behavioral and cognitive deficits are commonly observed in both neurodevelopmental disorders possibly through such overlapped transcripts.
We categorized these common genes by protein network analyses into four clusters: transcription regulation, regulation of actin cytoskeleton, ubiquitin-mediated proteolysis, and calcium signaling pathway. Although previous studies on FMRP targets have already suggested a limited number of molecules related with above functional categories, our results clearly highlight importance of the whole molecules involved in these categories in corticogenesis.
The largest number of mRNA targets we found are genes whose products are classified into "transcription regulation" that controls the proliferation of neural stem cells and their transition to differentiating neural progenitors (Lee et al., 2014) . One of the FMRP target in this category is Pax6, a key transcription factor in brain development by regulating hundreds of genes related to ASD (see review by Kikkawa et al., 2019) . The mRNA and protein expression of Pax6 in the Fmr1-KO mice showed a decreased tendency at below the significant level ( Figure S2 ). The lack of the significance can be attributed to small sample size and/or weakness in the experimental design; or the regulation of Pax6 by FMRP may not be due to transcriptional regulation.
A previous ChIP study has reported that Fmr1 is one of the targets of Pax6 (Sansom et al., 2009 ) and our preliminary work showed that FMRP expression was decreased in the Pax6 deficient cortical primordium (data not shown). A positive feedback loop between these two pivotal molecules, i.e., FMRP and Pax6, could be important when we consider pathogenesis of neurodevelopmental disorders.
The second category we found is "regulation of actin cytoskeleton". It is shown that FMRP regulates cell fate determination (Saffary and Xie, 2011) , neuronal migration and cortical circuitry (La Fata et al., 2014) , and maintenance of the scaffold of RGCs (Yokota et al., 2009 ) during brain development. Since these developmental processes are highly dependent on cytoskeletal organization, our mRNA targets of this category may play a role in these processes.
Another interesting group of genes that are considered to be ASD-related FMRP targets are related with "Ubiquitin-mediated proteolysis". Ubiquitination is not only important in mature neurons (Hallengren et al., 2013) but also in various neurodevelopmental processes such as synapse formation, neurogenesis, neurite enlargement, dendrite growth, axonal development, neural tube formation, and differentiation (Tuoc and Stoykova, 2010) . Although ubiquitin-related genes, i.e., Huwe1 and Ube3b are previously suggested as a target of FMRP in neurons (Darnell et al., 2011) , our data showing that FMRP can regulate 7 genes involved in the ubiquitin-mediated proteolysis may imply general importance of FMRP in ubiquitination.
Finally, we found ASD-related FMRP target genes categorized into "calcium signaling pathway", although their number was only five. A previous literature has already mentioned molecules related with calcium signaling, a key process in neural functions (Davis and Broadie, 2018) . This is quite expected because our original samples for RIP-seq were taken from the cortical primordium of E14.5, containing immature neurons where modulation of ion channels and regulation of excitability may occur. However, other possibility that calcium signaling is functioning within RGCs cannot be excluded.
In our study, we analyzed expression of ASD-related FMRP mRNA targets in the cortical primordium of Fmr1-KO by RT-qPCR. Only few studies have previously examined FMRP regulation on its targets at the mRNA level (Brown et al., 2001; Korb et al., 2017; Liu et al., 2018) . These reports do not directly demonstrate the mechanistic role of FMRP on the transcription of its target genes, but they provide clues that mRNA levels are altered if FMRP function is impaired.
Among the four ASD-related FMRP targets we found, Kat6a and Kmt2c are previously suggested to be FMRP mRNA targets from ribosomal profiling using adult neurons (Darnell et al., 2011) . Kat6a and Kmt2c are histone modification writers, which can epigenetically regulate transcription (Shen et al., 2014; Tapias and Wang, 2017) .
Interestingly, expression of Kat6a and Kmt2c were conversely regulated by loss of FMRP functions. Though we did not demonstrate the interaction between Kat6a and (Alpatov et al., 2014) .
Another ASD-related FMRP target that showed decreased expression in Fmr1-KO mice, Apc has previously been described as a target of FMRP (Darnell et al., 2011; Pilaz et al., 2016) , and loss of APC in the RGCs drastically disrupted RGC organization and inhibited appropriate proliferation of RGCs (Nakagawa et al., 2017) .
In our data, Apc expression was decreased in Fmr1-KO cortical primordium, which may actually affect proliferation and organization of RGCs during brain development.
The last ASD-related FMRP target, Huwe1, showed increase in expression in loss of FMRP function. Huwe1 is an a FMRP target in Drosophila oocytes, where decrease in Huwe1 expression has been suggested due to indirectly enhanced translation by preventing protein degradation (Greenblatt and Spradling, 2018) . The discrepancy can probably be accounted for by the function of FMRP in different tissues and that transcription of FMRP mRNA targets may also vary in different tissues (Zalfa et al., 2007; Man et al., 2017) . Further studies on the regulation of FMRP on Huwe1 during brain development might be relevant to understand its impact in the development of How does FMRP regulate transcription of its mRNA targets? In our study, Kmt2c showed reduced mRNA levels in Fmr1-KO embryonic brain, which might be due to loss of mRNA stability. Thus, we inferred that dysfunction of FMRP may reduce stabilization of Kmt2c mRNA, resulting in its decreased expression, which might contribute to impaired neural development in FXS.
Conversely, FMRP can also perturb gene expression like in cases of Huwe1 and Kat6a. This can be direct, but also be indirect since it has been proven that FMRP interacts with multiple other RNA-binding proteins (Davis and Broadie, 2018) . In case of a nuclear export factor NXF1, the absence of FMRP first inhibits NXF2 (also a nuclear export factor and close family of NXF1), which results in reduction of Nxf1 expression (Zhang, et al,, 2007; Davis and Broadie, 2018) . Changes of the gene expression levels of FMRP targets in the Fmr1-KO telencephalon could be regulated by FMRP directly or indirectly via other mechanisms i.e., epigenetic regulation and microRNAs.
In this study, we revealed that FMRP might interact with many mRNAs during mammalian corticogenesis. It is important to understand that not one single gene regulated by FMRP can explain a given phenotype of neurodevelopmental disorders.
Instead, it may arise from the collective dysregulation of combinatory sets of FMRP targets. Though we do not know how FMRP mechanistically manages its mRNA targets, our findings suggest that dysfunctions of FMRP may influence changes the fate of its mRNA targets in various ways, multiple combination of which can reflect multifarious phenotypes of neurodevelopmental disorders.
MATERIALS AND METHODS
Animals
Animal experiments were carried out in accordance with the National Institutes of Health guidelines outlined in the Guide for the Care and Use Laboratory Animals. The Committee for Animal Experimentation of Tohoku University Graduate School of Medicine approved all the experimental procedures described herein (2017-MDA-189).
Male WT (C57BL/6J) and Fmr1-KO mice (B6.129P2-Fmr1 tm1Cgr /J, stock #003025) (Bakker et al., 1994) were used in this study. Hemizygote (Fmr1 -/y ) male and heterozygote (Fmr1 +/-) female mice were mated to obtain WT (Fmr1 +/y ) and Fmr1-KO (Fmr1 -/y ) male embryos.
DNA extraction and genotyping
Deoxyribonucleic acid (DNA) was extracted from tail of E15.5 mouse embryos. A mixture of 10 µl of 5x Colorless GoTaq® Flexi Buffer (Promega). Standard polymerase chain reaction (PCR) was performed to determine gender and the WT and Fmr1 KO alleles of the embryos using specific primers ( Supplementary Table 2 , gifted by Dr.
Yukio Sasaki) and the GoTaq® Flexi DNA Polymerase (Promega). Standard PCR was performed using the Vapo Protect Thermal Cycler (Eppendorf), and the amplified PCR products were visualized by electrophoresis on 1% agarose gels using the Gel Doc TM EZ Imager (Bio-Rad).
Immunohistochemistry
WT and Fmr1-KO embryos at E15.5 were perfused with 4% paraformaldehyde (PFA) in phosphate buffered saline (PBS), and the whole brain was collected. The embryonic brain was fixed in 4% PFA in PBS at 4°C for 2 hours, placed in 10% sucrose/PBS 
In utero electroporation into mouse embryonic brain
In utero electroporation was performed as described previously with minor modification (Saito and Nakatsuji, 2001; Sato et al., 2013) . Pregnant WT mice at E13.5 were anesthetized with by isoflurane for laboratory animals (MSD Animal Health) using the Univentor 400 anaesthesia unit and vaporizer (Univentor). For surgery, the uterus of the pregnant mouse was exposed after making approximately 3 cm of incision in the middle abdominal region. The expression vectors pCAG-EGFP plasmid (kindly gifted from Prof. Tetsuichiro Saito, Chiba University, Japan) and 1% Fast green in PBS was injected into the lateral ventricle of embryos at E13.5 with a mouth-controlled glass capillary pipette. Immediately, square pulses (40 V, 50 ms, five times at 1 second intervals) were delivered into embryos with an electroporator (CUY-21, BEX) and a forceps-type electrode (LF650P5, BEX). After the electroporation, the uterus was returned back to inside of the abdomen and sutured with Suture with Needle kit (8 mm of diameter curved needle, 45 cm of thread, BEAR Medic Corporation). Finally, the most out layer of skin was clipped by 9 mm stainless steel AUTOCLIP Applier (Becton Dickinson and company). After surgery, mice were placed on a 37°C heating pad for recovery. Embryos were collected at E14.5 for further analysis.
Preparation of RNA libraries and sequencing
Following the manufacturer's protocol, RIP assay was performed to extract FMRP-bound mRNAs from the dorsal telencephalon of WT mice at E14.5 by using RiboCluster Profiler™ RIP-Assay Kit, anti-FMRP Human polyclonal antibody, #RN016P, and Dynabeads™ Protein beads G/A (Invitrogen™). The quality and quantity of the total RNA was evaluated using the Agilent 2100 Bioanalyzer with RNA 6000 Pico Kit (Agilent). Total RNA concentration greater than 50 ng with an RNA Integrity Number (RIN) value greater than or equal to 7.9 (≥7.9) were submitted to the Graduate School of Frontier Sciences, The University of Tokyo for next generation sequencing. A total of three cortices immunoprecipitated with anti-FMRP and two cortices immunoprecipitated with anti-IgG were sequenced.
Sequence alignment and estimation of gene expression levels
To trim the raw reads containing the Illumina adaptors and remove low quality sequences, the FASTX-Toolkit (http://hannonlab.cshl.edu/fastx_toolkit/) was used.
Quality reads below 20 and sequence length below 70 were discarded. Only good quality and paired reads were analyzed in the next step.
TopHat-Cuffdiff pipeline was employed to analyze the RNA sequences (http://tophat.cbcb.umd.edu/, http://cufflinks.cbcb.umd.edu/). Using TopHat, sequence reads were aligned to the Mus musculus genome (mm10) with default parameter values, except for distance between mature pairs (r=200), or the gap between paired reads. The final efficiency of alignment of all the sequences was between 72 to 87% ( Supplementary Table 3 ). Gene expression levels were calculated as fragment per kilobase of transcript per RNA-seq read mapped (FPKM) using Cuffdiff. We defined the enriched RNAs after FMRP pulldown as FMRP-IP and the negative control as IgG-IP. The fold change (FC) on a logarithmic scale with base 2 (log 2 FC) and p-value for each gene are calculated to statistically test differential expression between the two conditions (FMRP-IP versus IgG-IP). We only used genes showing nominally significant difference at Q<0.01, fold-change equal to or greater than 1, and FPKM value greater than 10 in the FMRP-IP samples in the subsequent analyses of differentially expressed genes (DEGs) ( Figure 2B) .
Gene Ontology and Protein Association Network
Functional annotation of the DEGs was performed using the VLAD tool (v1.6.0) of the MGI. GO was determined via an enrichment analysis (biological process) and the false discovery rate (FDR) less than 0.05 was considered as significantly enriched GO annotation ( Supplementary Table 4 ). Protein network analysis was performed using the STRING database of known and predicted protein-protein interactions (Szklarczyk et al., 2017) .
RNA extraction, quantitative PCR and RIP-qPCR
Total RNA was isolated with the RNeasy Mini Kit (Qiagen) according to the manufacturer's protocol. RIP-qPCR was performed to validate and quantify expression of the FMRP targets using the FMRP-IP and QC-input dorsal telencephalon samples (pooled from WT, n=3), and dorsal telencephalon samples from WT (n=7) and Supplementary Table 5 ) were designed by PrimerBank (https://pga.mgh.harvard.edu/primerbank/) and from previous reports (Duong et al., 2011; Bonnans et al., 2012; Armoskus et al., 2014; Korneev et al., 2015; Durak et al., 2016; Yasuma et al., 2016; Baell et al., 2018; Cheng et al., 2019) .
Western blot
Protein samples were collected from the pooled (n=3) dorsal telencephalon of WT and for 1 minute with three repeats and for 5 minutes with three repeats, and incubated with a secondary antibody, either of donkey anti-goat 800 (1:10000; Licor), goat anti-rabbit 680 (1:10000; Licor), or donkey anti-mouse 680 (1:10000; Licor), diluted in 10% blocking buffer with PBS for 1 hour at RT under a shaded condition. The fluorescence was detected using ODYSSEY infrared imaging system (Licor). The signals were quantified using ImageJ 1.48v software (NIH).
In situ hybridization
In situ hybridization was performed as previously described (Osumi et al., 1997; Kikkawa et al., 2013) . Frozen sections were incubated in Proteinase K (0.3 µg/ml) in PBS containing 0.1% Tween 20 (PBST) in 37°C water bath for 8 minutes. The sections were washed twice with PBST for 1 minute, and at RT for 2 minutes. The sections were then incubated in 4% PFA for 20 minutes. Ten-µl of RNA probe (50 ng/ml) was mixed with 150 µl of hybridization buffer (HB:100% Formamid, 20x SSC, 10% SDS, 50 µg/ml Heparin, 50 µg/ml tRNA from Escherichia coli (E. coli), diluted in RNase-free water). The Pax6 RNA probe was produced by cloning the WT cDNA fragment amplified with the following primers: 5'-TCAGCTTGGTGGTGTCTTTG-3' (sense) and 5'-GGTTGCATAGGCAGGTTGTT-3' (antisense). The amplified sequences (inserts) were ligated to Bluescript vector (Promega) and transformed in competent cells (E. coli DH5α). RNA probes were then synthesized using polymerases T3/T7 (Promega). The probes in HB were applied on the sections, covered with coverslip (GRACE Biolab), placed into a moisture chamber (COSMO BIO), and then incubated at 70°C for 14-16 hours.
The sections were washed in Solution I (100% Formamid, 20x SSC, 10% SDS, milliQ water) at 67.5°C for 30 minutes, twice with Solution III (100% Formamid, 20x SSC, milliQ water) at 67.5°C for 45 minutes, thrice with Tris-buffered saline containing 0.1% Tween-20 (TBST) at RT for 5 minutes, and followed by blocking with 0.5% Blocking Reagent in PBST at RT for 1 hour. The sections were incubated with anti-Digoxigenin-AP Fab fragments (α-DIG, 1:4000, Roche), placed in a moisture chamber, and incubated overnight at 4°C. For color reaction, the section were washed thrice with TBST for 20 min at RT, followed by NTMT solution (5M NaCl, 1M MgCl 2 , 2M Tris-HCL, 10% Tween 20, milliQ water) at RT for 5 minutes and then incubated in the color reaction reagent (NTMT solution, 50 mg/ml NBT, 50 mg/ml BCIP) until the signal started to show up (approximately 8-24 hours). The sections were mounted with VECTASHIELD mounting medium, and sealed with cover slides by EUKIT. Images were visualized by a bright field microscopy (Keyence BZ-X710 All-in-One Fluorescence Microscope).
Astrocyte culture
Astrocytes were cultured following essentially our study (Sakurai and Osumi, 2008) .
WT and Fmr1-KO pups at postnatal day 2 (P2) were anesthesized deeply and sterilized by dipping in 70% ethanol. Lateral cortices were dissected from hemispheres in 2 ml of ice-cold Tyrode's solution and dispersed mechanically in 1 ml of Dulbecco's modified eagle medium (DMEM) containing 10% fetal bovine serum (Sigma), 1% GlutaMAX (Gibco), and 1% antibiotic-antimycotic (Gibco). The dispersed cells were collected by centrifugation at 1000 rpm for 5 minutes, resuspended in 1 ml of medium, transferred into T75 flask with 10 ml of media, and cultured in the 37°C incubator (5% CO 2 ) for 9 days. Media was exchanged every 3 days. At day 9, the cultured astrocytes were rinsed three times with 5 ml of PBS and once with 5 ml of media. Ten-ml of fresh media was added into T75 flask and the flasks were incubated for over 2 hours to stabilize pH of media. The flasks were then shaken vigorously at 250-300 rpm in the 37°C incubator for 18-24 hours to remove contaminated neurons, oligodendrocytes, and microglia.
After shaking, cells were rinsed cells with 5 ml of PBS three times and incubated with 2 ml of trypsin-EDTA (Gibco) for 5 minutes. The enzymatic reaction was stopped by adding 8 ml of media, cells were collected by centrifugation at 1000 rpm for 5 minutes.
Cell pellets were resuspended in the media and resuspended cells were seeded at 10 6 cells/dish in 3.5-cm dishes. The primary astrocytes were cultured for 3 days and used for mRNA stability assay.
Mouse embryonic fibroblast culture
The protocol was according to that used in a previous study with minor modification (Durkin et al., 2016) . MEFs were derived from WT and Fmr1-KO E14.5 embryos. The head, internal organs and limbs were removed from the embryos, and the trunk was mechanically minced and transferred in a 50 ml tube with 10 ml in Hank's calcium magnesium free (HCMF) solution. HCMF solution was removed and replaced with 9 ml 0.25% trypsin-EDTA (Gibco), and samples were incubated at 37°C for 15 minutes.
To stop enzymatic reaction, 10 ml of DMEM was added and then the tubes centrifuged at 1000 rpm for 5 minutes. The sticky material and the supernatant were removed from the samples using a pipette. The remaining cells were re-suspended in in 10-mm plate containing 10 ml DMEM, containing 10% fetal bovine serum (Sigma), 1% GlutaMAX (Gibco), and 1% antibiotic-antimycotic (Gibco) and incubate in the 37°C incubator (5% CO 2 ). Cells were cultured for 9 days and used for mRNA stability assay.
mRNA stability assay
For blocking transcription, both cultured MEFs and astrocytes were incubated with 1 ml of media containing 10 µg/ml of actinomycin D (dissolve in dimethyl sulfoxide, DMSO) (Wako) following a previous protocol (Zalfa et al., 2007) After treatment for 2, 4 and 6 hours, the treated and untreated (DMEM and with 0.001% DMSO) cells were rinsed once with 1 ml of PBS, and collected with 1 ml of TRIzol (Invitrogen). RNA was extracted as following the instruction manual of TRIzol and further purified with RNeasy Mini Kit (Qiagen). Purified RNA was used for RT-qPCR.
Statistical analysis
Data were compiled using Microsoft Excel 2011 and Student's t-test was used to calculate statistical significance. Hypergeometric distribution was calculated using the webtool Hypergeometric Distribution Calculator (https://keisan.casio.com/exec/system/1180573201). Values of p<0.05 were considered significant. 
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